Table 2.

Clinical data and relative M371 expression of serum from analysed patients with malignant testicular germ cell tumours

Patient ID	Age (years)	Histology	Tumour size (mm)	Clinical stage	RQ M371
100	29	Seminoma	30	CS3	734.19
101	44	Seminoma	85	CS2	666.29
102	44	Seminoma	26	CS1	24.25
103	40	Seminoma	22	CS1	24.08
104	35	Seminoma	15	CS1	4.02
105	50	Seminoma	48	CS1	238.86
106	56	Seminoma	19	CS1	1.58
107	19	NS (80% Teratoma, 20% YST)	180	CS3	8779.97
108	30	Seminoma	29	CS1	12.21
109	37	Seminoma	68	CS1	374.81
110	36	Seminoma	22	CS1	46.53
111	26	Seminoma	46	CS2	760.08
112	41	Seminoma	24	CS1	8.46
113	36	Seminoma	32	CS1	359.54
114	25	NS (EC)	26	CS2	2574.36
115	21	NS (90% YST, 10% EC)	37	CS1	125.37
116	33	Seminoma	24	CS1	14.52
117	25	NS (EC)	24	CS1	2033.85
118	34	NS (EC)	n.a	CS2	15.22
119	31	NS (EC)	25	CS2	588.13

CS Clinical stage, EC Embryonal carcinoma, NS Non seminoma, YST Yolk sac tumor, RQ Relative quantity, n.a. not available